_____________________________________________________________________________________________________________________
© 2005-9  All Rights Reserved. NOD Pharmaceuticals, Inc.
NOD Pharmaceuticals, Inc. is a biotechnology company focusing on innovative delivery of
biopharmaceutical products and aims to be the leader in this field, particularly oral and microneedle
based delivery.

NOD has developed two key technologies for biopharmaceutical delivery:
Emerging Leader in innovative Biopharmaceutical Delivery
NOD
Pharmaceuticals, Inc.
Innovation Delivered
Recent Events
Nodlin is the oral insulin developed with NOD tech and is currently in Phase 1 trial.  Please visit our
News page for current events.